Nalaganje...
Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder resulting in vascular malformations of several organs including the pulmonary, cerebral, and gastrointestinal systems. One sequela is recurrent gastrointestinal (GI) bleeding. Bevacizumab (Bev) is emerging as an effective...
Shranjeno v:
| izdano v: | Case Rep Gastrointest Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8263270/ https://ncbi.nlm.nih.gov/pubmed/34306771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/2242178 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|